Could a shot stop mouth cancer before it starts?
NCT ID NCT06561087
First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times
Summary
This study tests if injecting the cancer drug nivolumab directly into high-risk precancerous mouth lesions can stop them from turning into cancer. About 45 adults with these lesions will receive either the drug or a placebo injection. The goal is to see if the treatment is safe and effective at controlling the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL PREMALIGNANT LESION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77090, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI eye on stomach cancer: 6,000-Person trial tests smarter scopes
- Genetically modified cells injected into mouth lesions to stop cancer before it starts
- AI to predict cancer risk from gut bacteria and scans
- Cancer drug injected directly into precancerous mouth spots shows promise in early trial
- Hunger training may help cut breast cancer risk in obese women
- Electric probe could spot mouth cancer without a biopsy